Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.28 USD | -2.78% | +1.51% | +67.96% |
May. 20 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
May. 14 | Enliven Therapeutics Q1 Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.96% | 1.13B | |
+10.00% | 118B | |
+10.33% | 106B | |
-11.20% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.46% | 15.97B | |
+6.88% | 14.03B | |
+17.77% | 11.67B |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Enliven Therapeutics Insider Sold Shares Worth $111,751, According to a Recent SEC Filing